AWS · 2026-04-14 · major
Amazon Bio Discovery — AI-Powered Drug Discovery on AWS
AWS launches Amazon Bio Discovery, an AI application for early-stage drug discovery that lets scientists run complex computational workflows without writing code, using specialized biological foundation models to generate and evaluate drug molecules.
Amazon's no-code AI platform that lets researchers discover drug candidates without writing code.
Key specs
| Capability | No-code workflows |
|---|---|
| Models | Biological foundation models |
What is it?
Amazon Bio Discovery is AWS's AI application for early-stage drug discovery. It provides access to a library of specialized biological foundation models that can generate and evaluate potential drug molecules, along with an AI agent that helps users select models, set parameters, and interpret results. Scientists can run complex computational workflows without writing code.
How does it work?
Researchers describe their target (e.g., a protein involved in a disease) and Bio Discovery's AI agent guides them through model selection, parameter configuration, and result interpretation. The platform accesses specialized foundation models for molecular generation, binding prediction, and ADMET property evaluation. Results are presented in an interactive interface for iterative refinement.
Why does it matter?
Drug discovery typically requires years and billions of dollars. AI is accelerating this dramatically — Insilico Medicine's fully AI-designed drug reached Phase IIa in 18 months with $6M in compute costs. Amazon Bio Discovery makes these capabilities accessible to researchers without ML expertise, potentially democratizing AI-driven pharma R&D.
Who is it for?
Pharmaceutical researchers, biotech startups, academic drug discovery labs.
Try it
Available on AWS for research teams.